Predict your next investment

Gasporox company logo
HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
gasporox.se

See what CB Insights has to offer

Founded Year

2005

Stage

Private Equity | Alive

Total Raised

$1.45M

Valuation

$0000 

Last Raised

$1.45M | 2 yrs ago

About Gasporox

Gasporox offers non-destructive gas sensor solutions for leak detection and headspace analysis for O2, CO2, H2O and the combined O2+H2O, for applications in the medical technology area and food products.

Gasporox Headquarter Location

Maskinvagen 1

Lund, 227 30,

Sweden

+46 (0)46 5405040

Latest Gasporox News

Nasdaq Stockholm Welcomes Gasporox to First North

Oct 25, 2016

Nasdaq Stockholm Welcomes Gasporox to First North October 25, 2016 04:15 ET | Source: Nasdaq Nordic Stockholm, October 25, 2016 — Nasdaq (Nasdaq: NDAQ) announces that the trading in Gasporox AB’s shares (short name: GPX) commenced today on Nasdaq First North in Stockholm. Gasporox belongs to the Industrial sector and is the 64th company to be admitted to trading on Nasdaq’s Nordic markets* in 2016. Established as a spin-off from Lund University in 2005, Gasporox is a technology company offering instruments and services for gas monitoring in food and pharmaceutical packages. The company’s products are based on so called diode laser spectroscopy, and are used for quality control in the food and pharmaceutical industries. Gasporox holds a number of world-wide patents and is headquartered in Lund, Sweden. For more information, please visit www.gasporox.se . "We are very happy about the huge interest we have received in our recent share issue and for the listing on First North,” said Märta Lewander Xu, CEO of Gasporox. “Our ambition is to give our new and potential future shareholders an interesting journey together with Gasporox. We believe that we can offer a unique product for quality control in food and pharma packages, and that our solution can help clients reduce costs in several parts of the production process. We strongly believe in our product and we are now shifting focus towards the commercialization of our technology. " “We welcome Gasporox to Nasdaq First North,” said Adam Kostyál, senior vice president and head of European listings at Nasdaq. “Gasporox will make a compelling addition to our Industrial sector, and we look forward to supporting the company with the increased investor visibility that comes with a First North listing.” Gasporox AB has appointed G&W Kapitalförvaltning AB as the Certified Adviser. *Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. About Nasdaq First North Nasdaq First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic (Nasdaq First North Denmark is regulated as an alternative marketplace). It does not have the legal status as an EU-regulated market. Companies at Nasdaq First North are subject to the rules of Nasdaq First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market. About Nasdaq Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of $10.0 trillion and approximately 18,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com . Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd., Nasdaq Iceland hf., Nasdaq Riga, AS, Nasdaq Stockholm AB, Nasdaq Tallinn AS, AB Nasdaq Vilnius, Nasdaq Clearing AB and Nasdaq Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius. Cautionary Note Regarding Forward-Looking Statements The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements. Media Relations Contact:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Gasporox Patents

Gasporox has filed 13 patents.

The 3 most popular patent topics include:

  • Spectroscopy
  • Industrial gases
  • Gases
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/5/2017

2/23/2021

Spectroscopy, Analytical chemistry, Interferometry, Optical devices, Interferometers

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

10/5/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

2/23/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Spectroscopy, Analytical chemistry, Interferometry, Optical devices, Interferometers

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Gasporox Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Gasporox Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.